The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date

AA Kolkailah, M Iskander, F Iskander, PP Patel… - Journal of Nuclear …, 2022 - Elsevier
Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …
被引用次数：15 相关文章

THE PROGNOSTIC UTILITY OF REGADENOSON SPECT MYOCARDIAL PERFUSION IMAGING IN PATIENTS WITH END-STAGE RENAL DISEASE: THE LARGEST …

A Kolkailah, M Iskander, F Iskander, R Khan… - Journal of the American …, 2020 - jacc.org
Background There is paucity of data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date

AA Kolkailah, M Iskander, F Iskander… - Journal of nuclear …, 2022 - pubmed.ncbi.nlm.nih.gov
Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date.

AA Kolkailah, M Iskander, F Iskander… - Journal of Nuclear …, 2022 - search.ebscohost.com
Background: There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date

AA Kolkailah, M Iskander, F Iskander, PP Patel… - Journal of Nuclear … - Springer
Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date.

AA Kolkailah, M Iskander, F Iskander… - Journal of Nuclear …, 2020 - europepmc.org
Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date

AA Kolkailah, M Iskander… - Journal of …, 2022 - journalofnuclearcardiology.org
Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …